Literature DB >> 25243893

Resistant hypertension and associated comorbidities in a veterans affairs population.

Tushar Acharya1, Steven Tringali, Manmeet Singh, Jian Huang.   

Abstract

Resistant hypertension (RH) is understudied and its reported prevalence varies with study populations. The authors sought to determine its prevalence and association with certain comorbid conditions in a Veterans Affairs population. This cross-sectional study utilized demographic and clinical data from 17,466 patients. Chi-square or t test was used for comparing groups with and without RH. Multivariate logistic regression analysis was used to determine independent associations. Overall, the prevalence of RH was 9%, and 13% of all hypertensive patients met criteria for RH. After adjusting for confounding variables, RH was significantly associated with older age (odds ratio [OR], 1.007), higher body mass index (OR, 1.04), Framingham score (OR, 1.14), and coexisting coronary artery disease, cerebrovascular accident/transient ischemic attack, peripheral vascular disease, congestive heart failure, chronic kidney disease, diabetes mellitus, erectile dysfunction, and metabolic syndrome (OR, 1.3, 1.32, 1.29, 2.88, 2.13, 1.2, 1.12, and 1.2, respectively; all P<.05). Our results indicate a complex interplay of certain comorbid conditions among patients with RH and suggest the need for multifaceted interventions in this high-risk population to prevent cardiovascular events.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25243893      PMCID: PMC8031950          DOI: 10.1111/jch.12410

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  31 in total

1.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

2.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

3.  Hypertension and the "J-curve".

Authors:  Bryan Williams
Journal:  J Am Coll Cardiol       Date:  2009-11-10       Impact factor: 24.094

4.  Resistant hypertension: incidence, prevalence, and prognosis.

Authors:  Eduardo Pimenta; David A Calhoun
Journal:  Circulation       Date:  2012-02-29       Impact factor: 29.690

Review 5.  The kidney, hypertension, and obesity.

Authors:  John E Hall
Journal:  Hypertension       Date:  2003-01-20       Impact factor: 10.190

6.  Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon; Walter A Brzezinski; Keith C Ferdinand
Journal:  Circulation       Date:  2011-08-08       Impact factor: 29.690

7.  Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity.

Authors:  Guido Grassi; Anna Facchini; Fosca Quarti Trevano; Raffaella Dell'Oro; Francesca Arenare; Francesco Tana; GianBattista Bolla; Anna Monzani; Maria Robuschi; Giuseppe Mancia
Journal:  Hypertension       Date:  2005-06-27       Impact factor: 10.190

8.  Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

Authors:  Shaista Malik; Nathan D Wong; Stanley S Franklin; Tripthi V Kamath; Gilbert J L'Italien; Jose R Pio; G Rhys Williams
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

9.  Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

Authors:  Elizabeth Selvin; Thomas P Erlinger
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

10.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

View more
  10 in total

1.  Resistant hypertension: do all definitions describe the same patients?

Authors:  L Boswell; J Pascual; A Oliveras
Journal:  J Hum Hypertens       Date:  2015-01-15       Impact factor: 3.012

2.  Prevalence of Apparent Treatment-Resistant Hypertension in the United States.

Authors:  Robert M Carey; Swati Sakhuja; David A Calhoun; Paul K Whelton; Paul Muntner
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

3.  Lobar intracerebral hemorrhage and risk of subsequent uncontrolled blood pressure.

Authors:  Evangelos Pavlos Myserlis; Ernst Mayerhofer; Jessica R Abramson; Kay-Cheong Teo; Bailey E Montgomery; Lansing Sugita; Andrew D Warren; Joshua N Goldstein; Mahmut Edip Gurol; Anand Viswanathan; Steven M Greenberg; Alessandro Biffi; Christopher D Anderson; Jonathan Rosand
Journal:  Eur Stroke J       Date:  2022-04-27

4.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 5.  New Molecules for Treating Resistant Hypertension: a Clinical Perspective.

Authors:  Omar Azzam; Marcio G Kiuchi; Jan K Ho; Vance B Matthews; Leslie Marisol Lugo Gavidia; Janis M Nolde; Revathy Carnagarin; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2019-09-10       Impact factor: 5.369

6.  Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.

Authors:  John J Sim; Simran K Bhandari; Jiaxiao Shi; Kristi Reynolds; David A Calhoun; Kamyar Kalantar-Zadeh; Steven J Jacobsen
Journal:  Kidney Int       Date:  2015-05-06       Impact factor: 10.612

7.  Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology.

Authors:  Stefano Bianchi; Filippo Aucella; Luca De Nicola; Simonetta Genovesi; Ernesto Paoletti; Giuseppe Regolisti
Journal:  J Nephrol       Date:  2019-05-22       Impact factor: 3.902

8.  Prevalence and prognosis of the 2018 vs 2008 AHA definitions of apparent treatment-resistant hypertension in high-risk hypertension patients.

Authors:  Kyeong-Hyeon Chun; Chan Joo Lee; Jaewon Oh; Sang-Hak Lee; Seok-Min Kang; Kazuomi Kario; Sungha Park
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-20       Impact factor: 3.738

9.  Prevalence and clinical outcomes of patients with apparent treatment-resistant hypertension enrolled in Phase 2 cardiac rehabilitation.

Authors:  Luke J Laffin; Asad Khan; Katherine Lang; Erik H Van Iterson
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-23       Impact factor: 3.738

10.  Resistant hypertension and associated comorbidities in a veterans affairs population.

Authors:  Tushar Acharya; Steven Tringali; Manmeet Singh; Jian Huang
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-09-19       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.